# Outpace Bio: Research, Seattle, United States

> Outpace Bio: Outpace Bio is a clinical-stage biotechnology company based in Seattle, Washington. Based in Seattle, United States. Founded 2020.

Source: https://millionrounds.com/startup/outpace-bio (Millionrounds; every figure on the page links to its filing or article)

United States · [Research startup](https://millionrounds.com/companies)

# Outpace Bio

Outpace Bio is a clinical-stage biotechnology company based in Seattle, Washington.

Funding reported Last round: Series B

Research Seattle, United States

Company summary

- **Founded:** 2020 6 years old
- **Team:** 74 51 to 200 people
- **Funding reported:** $199M in dollars
- **Last round:** Series B Aug 2024

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Outpace Bio has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Outpace Bio

Outpace Bio is a clinical-stage biotechnology company based in Seattle, Washington.

Founded in 2019, the company specializes in AI-powered protein design to develop next-generation T cell therapies, including CAR-T and TCR-T, aimed at treating solid tumors. Their mission is to enhance the efficacy and safety of these therapies, addressing the challenges faced in treating the 95% of cancers that are solid tumors. The company utilizes a modular platform that combines computational protein design, machine learning, synthetic biology, and immunology. This innovative approach allows Outpace Bio to create engineered T cell therapies with improved tumor access, functional persistence, and reduced toxicity. Their lead programs include OPB-101, a CAR-T therapy targeting mesothelin for ovarian cancer, and OPB-201, a TCR-T therapy for endometrial cancer. Outpace Bio also engages in strategic collaborations and technology licensing to integrate its solutions into other cell therapy products, further advancing the field of cancer treatment.

## What company datasets say Outpace Bio raised

Funding, as reported

Reported in all **$199M** in dollars

Rounds **3**

Last round **Series B**

Last round size **$144M**

Last round date **Aug 2024**

Investors listed **18**

SEC Form D **$56M sold, 1 filing, last Aug 2024**

## On 4 portfolio pages

Investors who name them

- [Atinum Investment](https://millionrounds.com/fund/atinum-investment)
- [Civilization Ventures](https://millionrounds.com/fund/civilization-ventures)
- [Modi Ventures](https://millionrounds.com/fund/modi-ventures)
- [Playground Global](https://millionrounds.com/fund/playground-global)

Each firm lists Outpace Bio on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

biological feedback control health care tumor microenvironment biotechnology research modular assets manufacturing cell therapy cell engineering biotech funding therapeutic proteins medical research protein interaction specificity information technology & services safety switches targeted therapy biomolecular engineering

Built with from their website

GitHub Actions Amazon CloudFront WordPress.org AWS CodeDeploy Atlassian Lever Google Workspace CloudFlare Akamai Connected Cloud Viewport Meta

+8 more

Google Drive Element UI PostgreSQL Webflow Hosting Dask Apple Business Manager Google Meet GlobeNewswire

- **Sector:** Research
- **Industry code:** NAICS 541714, SIC 2834
- **Region:** Washington
- **Revenue:** $1.0M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/outpace-bio)

## Research in United States

Startups like it

- [**OpenAI** San Francisco · founded 2011 *Raised*](https://millionrounds.com/company/openai)
- [**Retro Biosciences** Redwood City · founded 2021 *Raised*](https://millionrounds.com/company/retro-biosciences)
- [**NewLimit** South San Francisco · founded 2022 *Raised*](https://millionrounds.com/company/newlimit)
- [**Pathos** New York · founded 2022 *Raised*](https://millionrounds.com/company/pathos)
- [**Colossal Biosciences** Dallas · founded 2021 *Raised*](https://millionrounds.com/company/colossal-biosciences)
- [**Oratomic** South Pasadena *Raised*](https://millionrounds.com/company/oratomic)
- [**Beeline Medicines** Stamford · founded 2025 *Raised*](https://millionrounds.com/company/beeline-medicines)
- [**Element Biosciences** San Diego · founded 2017 *Raised*](https://millionrounds.com/company/element-biosciences)

## Is this your company?

Add your raise, your deck and your story, and put Outpace Bio in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)